PharmaShots
APRIL 25, 2023
Numerous pharmaceutical companies have developed and authorized vaccines to provide immunity against COVID-19. Despite the drenched market of covid products, many other drugs have set an impressive benchmark for pharmaceutical companies in 2021. Watch out for the full report on Dupixent tomorrow. Stay tuned!
Pharma Marketing Network
JANUARY 6, 2021
Pharma marketers have quickly learned how to adapt to these trends and are prepared to take on new opportunities in 2021. Tools that help people track their health, including apps, wearables, and patient portals will be used more than ever in 2021. For example, people mistrust the efficiency and safety of the COVID-19 vaccine.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
JANUARY 31, 2022
It is becoming increasingly important for people all over the world to understand the importance of vaccines and to have access to the vaccines they need – especially with digital innovation driving new vaccine development. Pfizer’s Josh Raysman, Saad Saeed, and Shanaya Deboo discuss vaccine awareness, access, and innovation.
European Pharmaceutical Review
OCTOBER 24, 2022
The number of industry clinical trials initiated in the UK, per year, fell by 41 percent from 2017 to 2021, according to the latest annual report on clinical research from the Association of the British Pharmaceutical Industry ( ABPI ). million people living with rare diseases in the UK.
Pharma Mirror
SEPTEMBER 11, 2022
Bandung, W Java, Indonesia, PT Bio Farma, the holding company for state-owned pharmaceutical companies in Indonesia, announced a new milestone in the manufacturing of IndoVac, a Covid-19 vaccine brand it has developed since November 2021.
Pharmaceutical Technology
APRIL 21, 2023
US-based biopharmaceutical company Blue Water Vaccines has signed an asset purchase agreement with Veru to buy its Entadfi (finasteride and tadalafil) capsules business, for a total consideration of $100m. The US Food and Drug Administration granted approval to Entadfi for the treatment of BPH in December 2021.
Pharmaceutical Technology
FEBRUARY 8, 2023
The 13 top players experienced significant growth over 2022 despite the decline in demand for COVID-19 vaccines and therapeutics, as well as uncertainty surrounding pricing due to the newly passed Inflation Reduction Act in the US. billion between Dec 31, 2021 and Dec 31, 2022, owing to expansion in its vaccine and oncology portfolio.
Expert insights. Personalized for you.
56 
Let's personalize your content